Insulet stock heads into the open after a 3.1 percent drop
Published on 09/10/2026 at 06:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Insulet stock closed at USD 137.92 on the Nasdaq on September 9, 2026, down 3.1 percent. The stock also remained well below its 52-week high of USD 354.88 and above its 52-week low of USD 126.40.
On September 9, 2026, Insulet Corporation (ISIN US45784P1012) used the Wells Fargo 21st Annual Healthcare Conference to discuss the guidance cut that had weighed on the shares, as Investing.com reported. In that transcript, management said the setback was driven mainly by higher-than-expected attrition and lower utilization in type 2 diabetes. The same report also put the shares near USD 137.45 and described nearly 60 percent loss over the past year.
Insulet is also due at the Investing.com-covered conference backdrop today, with investors still focused on the companys response to the type 2 retention issue and the updated operating assumptions discussed there.
